Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
D000818:Animals; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D003345:Corticosterone / Q000097:blood; D004327:Drinking Behavior / Q000187:drug effects; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood; D011804:Quinolines / Q000494:pharmacology*; D011814:Quipazine / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism / Q000502:physiology*; D013569:Synapses / Q000187:drug effects
D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D011804:Quinolines; C018406:1-(3-trifluoromethylphenyl)piperazine; D012701:Serotonin; D011814:Quipazine; D006897:Hydroxyindoleacetic Acid; D011388:Prolactin; D003345:Corticosterone